NIH Institute / Center · GM (NIGMS)
National Institute of General Medical Sciences
483 funded awards, $296.6M total, FY2023-FY2025.
NIH SBIR/STTR funding decisions are made by Institutes and Centers based on portfolio priorities, NOFO scope, and program officer judgment. Historical funding patterns do not guarantee future funding.
Technology areas funded by NIGMS
Limitations
- RePORTER includes funded projects only, not unfunded applications.
- Panel sidebar reflects panels that have appeared on funded records, not future assignment.
- FOA-route status reflects verification at the timestamp shown.
Pattern read
NIGMS has been an active SBIR funder at 483 records / $297M. The portfolio is broad and method-focused: small-molecule discovery tools, basic-mechanism research tools, computational/bioinformatics platforms, and ML-driven biology. Median award is $511K. R44 dominates (277), R43 at 147; STTR participation (R41 at 33) is modest. Concentration is low at 5.8%. NIGMS's mission scope is basic biomedical science, not disease-specific work. Products framed around a specific disease indication have generally been a poor fit even when the underlying technology was strong.